l carnitine and memory Brain Health Plus Acetyl L-Carnitine

Both forms provide the same amount per serving

Regulatory B cells control dendritic cell functions

doi:10.1016/j.clinph.2012.12.049 40

57 The downregulation of RIPK3 in macrophages can activate PPAR, leading to the upregulation of FAO and M2 polarization

Who responds best to CagriSema Ideal candidates: Significant obesity (BMI 30-40+) Previously plateaued on GLP-1s alone Need maximum weight loss Good GI tolerability Metabolic syndrome or diabetes Commitment to long-term use Excellent responders: Higher baseline weight (more to lose) Good adherence to protocol Combine with diet/exercise Younger patients (better metabolism) No significant medication interactions May respond less optimally: Very low starting weight (BMI 30%): Nausea (most common) Decreased appetite (intended effect) Constipation Fatigue (especially first months) Common (10-30%): Vomiting (if nausea not managed) Diarrhea (alternating with constipation) Abdominal pain/discomfort Headache Dizziness Less common ( 40 with comorbidities Insurance covers surgery Want permanent solution Don't want ongoing injections Sourcing cagrilintide and semaglutide Obtaining these peptides requires understanding current availability

Clinical profile of primary sclerosing cholangitis in Singapore